Anti-Mouse CD273 (B7-DC) Purified

Also known as: B7DC, PD-L2, PDL-2, PDL2

Clone: TY25

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-5986

Cat. No. Size
14-5986-81 50 ug
14-5986-82 100 ug
14-5986-85 500 ug

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD273 (B7-DC) Purified.

Click on image to view more information.

More Views

  • Data for Anti-Mouse CD273 (B7-DC) Purified.
Description

Description: The TY25 monoclonal antibody reacts with mouse B7-DC/PD-L2. B7-DC, a member of the B7 family, has a predicted molecular weight of ~25 kDa and belongs to the Ig superfamily. The mouse B7-DC has a short cytoplasmic tail (4aa). B7-DC is primarily expressed by sub-populations of dendritic cells, monocytes and macrophages. Although B7-DC has structural and sequence similarities to the B7 family, it does not bind CD28/CTLA-4, but binds PD-1. The interactions between PD-1 and B7-DC/PD-L2 have been reported to be involved in costimulation or suppression of T cell proliferation depending on state of cellular activation. TY25 is a useful tool to study the exact function of B7-DC/PD-L2 in APC/T cell interaction and to characterize the expression pattern of this molecule in mouse.

Details
Host Rat
Isotype IgG2a, kappa
Reactivity Mouse
Conjugate Purified
Reported Applications Flow Cytometric Analysis, Immunohistochemical Staining of Frozen Tissue Sections, Functional Assays, Immunoprecipitation, Western Blotting
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
16-5986 Anti-Mouse CD273 (B7-DC) Functional Grade Purified FC, FA RUO
13-5986 Anti-Mouse CD273 (B7-DC) Biotin FC RUO
12-5986 Anti-Mouse CD273 (B7-DC) PE 488 nm 575 nm FC RUO
References

References: Aramaki O, Shirasugi N, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Azuma M, Okumura K, Yagita H, Niimi M. 2004. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation. Jan 15;77(1):6-12.

Tseng SY, Otsuji M, et al. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193(7): 839-46.

Carter L, Fouser L, et al. 2002. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32(3): 634-43.

Latchman Y, Wood CR, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2(3): 261-8.

Yamazaki T, Akiba H, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002 Nov 15;169(10):5538-45.

Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, Watanabe M. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol. 171(8):4156-63.

Mohammed Javeed I. Ansari, Alan D. Salama, Tanuja Chitnis, R. Neal Smith, Hideo Yagita, Hisaya Akiba, Tomohide Yamazaki, Miyuki Azuma, Hideyuki Iwai, Samia J. Khoury, Hugh Auchincloss, Jr. and Mohamed H. Sayegh. 2003. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice. J Exp Med 198 (1): 63-69.

Tanaka K., M. Albin et al. 2007. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol 179(8):5204-5210. (FA, PubMed)